Cellular accumulation of the anticancer agent cisplatin: a review.
about
Role of copper transporters in platinum resistancePharmacogenomics of cisplatin sensitivity in non-small cell lung cancerThe path for metal complexes to a DNA targetBiochemical characterization of P-type copper ATPasescis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospectsChemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of actionThe Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsThe association between copper transporters and the prognosis of cancer patients undergoing chemotherapy: a meta-analysis of literatures and datasetsCombination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cellsMetallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis.Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells.Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2).Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin.Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer.Encapsulation in nanoparticles improves anti-cancer efficacy of carboplatin.Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 yearsCellular responses to Cisplatin-induced DNA damage.2,3,7,8-Tetrachlorodibenzo-p-dioxin induced cell-specific drug transporters with acquired cisplatin resistance in cisplatin sensitive cancer cells.Interaction of liposome-encapsulated cisplatin with biomolecules.Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals.Understanding and improving platinum anticancer drugs--phenanthriplatinCopper transporter 2 regulates endocytosis and controls tumor growth and sensitivity to cisplatin in vivo.Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs.Apoptosis-related mRNA expression profiles of ovarian cancer cell lines following cisplatin treatment.Detection of platinum-DNA adducts by 32P-postlabelling.New clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA.An adsorptive transfer technique coupled with brdicka reaction to reveal the importance of metallothionein in chemotherapy with platinum based cytostatics.Exosomes: decreased sensitivity of lung cancer A549 cells to cisplatinGender difference in Cisplatin-induced nephrotoxicity in a rat model.Cross-resistance between cisplatin, antimony potassium tartrate, and arsenite in human tumor cells.Pressure tuning infrared spectroscopic study of cisplatin-induced structural changes in a phosphatidylserine model membrane.On the discovery, biological effects, and use of Cisplatin and metallocenes in anticancer chemotherapyp53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical studyTumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression.Tissue platinum concentration and tumor response in non-small-cell lung cancerOngoing and unsaid on oxaliplatin: the hopeIn vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473The antitumor efficiency of combined electrochemotherapy and single dose irradiation on a breast cancer tumor model.Cisplatin nephrotoxicity: molecular mechanisms.[Pt(O,O'-acac)(gamma-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway
P2860
Q26767028-77683D40-340B-487B-9215-AD06C2200071Q26863490-620FC35E-1863-4A74-B28F-EB07A986CD92Q26999667-8D64149A-EC0D-4517-A315-F8FA2C6020F8Q27021310-8E13587F-3E63-4A1B-B16F-1172AF8A7A88Q27650949-D69F4ACB-53A0-4095-B2C9-E79B8980317CQ27693179-831BEFAC-ACBD-4602-A0DC-9DD699EB3C39Q28066801-328220C8-E2E1-4AFB-AFCE-5CB4F76A89BDQ28074028-A4E99F7F-9E83-4044-91DE-AAC8B18BCA97Q28368394-C51E7404-0D37-49F1-A98F-4A6A83694A59Q30494430-CBEE5948-3147-4B7D-999A-4DA2520A1F86Q33345021-7268788D-C7CD-482A-A667-3E3F9166C1F1Q33523365-95D2A56B-DDBE-4B41-9407-516628BE419CQ33822719-A1671F93-26BF-4A18-A427-9B0DB231B929Q33875938-B4B8F235-2A52-46A2-83D9-560205914677Q33962540-FD205851-E210-401A-8C26-3BBDD6A5B6CDQ34008793-638A9BAA-895C-4FAA-9462-CDD3C42972D0Q34089685-3E998C93-77BB-4702-88EB-8F1AD74F0B2DQ34208237-41E291B6-21D5-46FC-9F41-280D8EF037CBQ34295156-1BCB4DB9-13F2-48B1-B696-418CC2B02DBFQ34393336-BD13F07E-2F60-492C-8A6D-882968D2A1E9Q34396623-91C2FA0D-AC69-40A3-9B3C-2068D2725811Q34458507-D9C260C6-C774-4CC3-B176-D77E707638D1Q34500340-B79FDC63-317E-40E7-AFD9-5F6EE3020619Q34517743-8093EB97-FFC9-4A3E-B797-B0639279017FQ34746244-9A7E0C8D-8D21-430A-9C94-ABA154DD4A24Q34914365-5DB67132-9083-40EC-9B91-D79B95103F9DQ35002247-480EA4FB-8F19-439D-AA5A-166FE6700E56Q35107566-7ED44076-1143-4C5E-AD3F-ED6E0FE33A23Q35367670-C4734223-87D3-4373-B208-088FE036706FQ35553372-42994EAB-E50C-483D-82FD-C5D544451A47Q36081734-F42672A3-704A-45C8-92E9-B6101C730913Q36107216-D507FF82-85EF-4315-A718-08C03303B192Q36115950-5E0869CD-E132-41AE-87D1-7418E53D36E2Q36134626-C0992B7E-B4D3-4323-AAA9-49F5800B0294Q36222930-9C7DF8DC-1BAB-4F10-B1CF-9CA42CAE5DB0Q36291594-98BDF4CD-C12E-41B6-A80F-7612672FE090Q36295090-EECE8B3F-B3DB-4412-A572-04DCAD85F703Q36322400-2338A917-9940-4874-A4E8-439349EDB63DQ36334357-3482B29E-E8A5-44D0-9842-62FF2838AEA7Q36381494-5F2785C0-D448-4705-AB0C-5EBEDAFD27AD
P2860
Cellular accumulation of the anticancer agent cisplatin: a review.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Cellular accumulation of the anticancer agent cisplatin: a review.
@en
type
label
Cellular accumulation of the anticancer agent cisplatin: a review.
@en
prefLabel
Cellular accumulation of the anticancer agent cisplatin: a review.
@en
P2860
P356
P1476
Cellular accumulation of the anticancer agent cisplatin: a review.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1993.221
P407
P577
1993-06-01T00:00:00Z